BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 in Immunotherapy

BioLineRx Ltd. , a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that an Issue of Notification has been received from the United States Patent and Trademark Office for U.S. Patent No.

http://ift.tt/1oTbe2R